Work

A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0M0 Prostate Cancer

Year: 2023

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2023.06.1578

Authors: J. Nicholson, B.D. O'Neill, P. Thirion, M. Cunningham, G. McVey, J. Coffey, A.M. Mihai, P.J. Kelly, N. Elbeltagi, M. Dunne, E. Noone, I. Parker, A.M. Shannon, M. McCague, A. Alvarez-Iglesias, H. Kelly, R. O'Donovan, D. Hajdaraj, G. Lawler, J.G. Armstrong

Institutions: St. Luke's Hospital, Cancer Trials Ireland, Cork University Hospital, Ollscoil na Gaillimhe – University of Galway

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Urology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387207112

FWCI:

Cites:

Cited by:

Related to: 10